Work

Plasma Concentration of ST2, the IL33 Receptor, At Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

Year: 2011

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v118.21.152.152

Authors: Mark T. Vander Lugt, Thomas Braun, James L.M. Ferrara, Samir Hanash, John E. Levine, Chee-Hong Wang, Qing Zhang, Alice Chin, Andrew C. Harris, Sung W.J. Choi, Daniel Couriel, Pavan Reddy, Sophie Paczesny

Institutions: University of Michigan, Fred Hutch Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980001575

FWCI:

Cites:

Cited by:

Related to: 10